Delayed response to phenobarbital treatment of a Crigler-Najjar type II patient with partially inactivating missense mutations in the bilirubin UDP-glucuronosyltransferase gene. J Pediatr Gastroenterol Nutr 1999 Feb;28(2):210-3
Date
02/05/1999Pubmed ID
9932859DOI
10.1097/00005176-199902000-00024Scopus ID
2-s2.0-0033020014 (requires institutional sign-in at Scopus site) 10 CitationsAuthor List
Ciotti M, Werlin SL, Owens ISAuthor
Steven L. Werlin MD Emeritus Professor in the Pediatrics department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
BilirubinCrigler-Najjar Syndrome
Fluid Therapy
Glucuronosyltransferase
Humans
Hyperbilirubinemia
Infant, Newborn
Male
Mutation, Missense
Phenobarbital
Phototherapy
